Clearpoint Neuro Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.3% | 41.4% | 37.5% | 40.4% | 40.1% | 39.2% | 36.3% | 36.6% | 30.6% | 30.3% | 35.9% | 39.5% | 33.6% | 29.1% | 29.9% | 32.4% | 25.7% | 38.5% | 35.1% | 32.9% | 33.5% | 23.2% | 35.8% | 37.4% | 28.5% | 35.9% | 41.1% | 47.5% | 43.2% | 41.1% | 40.8% | 36.5% | 40.3% | 38.7% | 39.5% | 39.7% | 36.8% | 38.5% | 37.8% | 36.4% | 37.4% | |
| 53.7% | 58.6% | 62.5% | 59.6% | 59.9% | 60.8% | 63.7% | 63.4% | 69.4% | 69.7% | 64.1% | 60.5% | 66.4% | 70.9% | 70.1% | 67.6% | 74.3% | 61.5% | 64.9% | 67.1% | 66.5% | 76.8% | 64.2% | 62.6% | 71.5% | 64.1% | 58.9% | 52.5% | 56.8% | 58.9% | 59.2% | 63.5% | 59.7% | 61.3% | 60.5% | 60.3% | 63.2% | 61.5% | 62.2% | 63.6% | 62.6% | |
| 42.8% | 32.4% | 27.8% | 54.9% | 34.3% | 34.7% | 33.7% | 40.4% | 34.2% | 21.1% | 23.6% | 26.8% | 26.0% | 27.3% | 26.3% | 32.8% | 32.5% | 49.1% | 38.8% | 62.2% | 56.9% | 63.8% | 57.7% | 46.4% | 51.6% | 70.0% | 55.6% | 60.6% | 42.2% | 38.9% | 34.4% | 39.7% | 40.8% | 42.9% | 39.8% | 41.6% | 39.0% | 31.1% | 37.3% | 42.6% | 37.5% | |
| 116.7% | 256.3% | 49.0% | 47.4% | 50.5% | 75.0% | 58.7% | 66.1% | 59.7% | 53.0% | 37.7% | 39.5% | 35.2% | 40.8% | 40.9% | 49.0% | 35.6% | 33.8% | 41.1% | 58.1% | 53.3% | 63.0% | 43.3% | 51.2% | 46.6% | 18.8% | 54.4% | 53.4% | 50.3% | 39.9% | 37.2% | 35.3% | 38.8% | 41.6% | 48.1% | 36.8% | 36.0% | 56.1% | 41.2% | 51.0% | 46.3% | |
| 159.5% | 168.1% | 130.0% | 151.8% | 137.2% | 169.9% | 151.6% | 162.8% | 136.1% | 112.7% | 103.5% | 110.1% | 97.5% | 115.1% | 108.9% | 127.2% | 110.5% | 122.4% | 119.0% | 166.9% | 149.7% | 169.8% | 141.0% | 143.4% | 145.2% | 150.5% | 164.1% | 172.4% | 141.8% | 128.0% | 114.6% | 123.8% | 123.4% | 133.4% | 133.1% | 121.9% | 122.7% | 129.2% | 132.1% | 157.7% | 136.0% | |
| -105.8% | -109.5% | -67.4% | -92.2% | -77.3% | -109.1% | -87.9% | -99.4% | -66.7% | -43.0% | -39.3% | -49.6% | -31.1% | -44.2% | -38.8% | -59.5% | -36.1% | -61.0% | -54.1% | -99.8% | -83.2% | -93.0% | -76.8% | -80.8% | -73.7% | -86.4% | -105.1% | -119.8% | -85.0% | -69.1% | -55.4% | -60.3% | -63.7% | -72.1% | -72.6% | -61.6% | -59.5% | -67.7% | -69.9% | -94.2% | -73.4% | |
| 14.9% | 13.2% | 10.6% | 10.8% | 12.3% | 14.0% | 15.2% | 15.1% | 13.7% | 10.5% | 10.3% | 9.9% | 7.3% | 7.1% | 27.0% | 8.0% | 5.7% | 5.5% | 8.2% | 7.0% | 5.2% | 3.8% | 2.1% | 1.8% | 0.6% | 1.6% | 2.1% | 1.4% | – | 2.8% | – | – | – | – | 0.0% | 0.9% | 6.1% | 6.8% | 11.4% | 13.0% | 9.6% | |
| -158.6% | -102.8% | -82.5% | -101.4% | -83.0% | -124.0% | -101.1% | -114.0% | -79.0% | -53.5% | -49.4% | -59.5% | -38.4% | -51.3% | -65.9% | -67.0% | -42.2% | -42.6% | -63.0% | -109.7% | -87.0% | -96.9% | -78.7% | -82.8% | -73.6% | -84.8% | -103.2% | -118.5% | -83.5% | -67.8% | -54.3% | -56.1% | -61.2% | -69.3% | -70.8% | -63.1% | -66.4% | -74.8% | -78.7% | -104.5% | -81.8% | |
| 12.4% | 13.6% | 10.8% | 10.7% | 5.7% | 13.2% | 13.1% | 14.6% | 12.4% | – | 10.5% | 10.0% | 7.3% | 5.1% | 25.0% | 5.1% | 5.4% | 29.4% | 7.6% | -1.1% | 6.6% | 3.8% | 1.9% | 1.9% | -0.1% | -1.6% | -4.0% | -1.4% | -7.3% | 10.6% | 0.2% | – | – | -5.5% | 0.2% | 0.3% | 0.1% | 0.0% | 0.1% | -0.3% | 0.0% | |
| -158.6% | -102.8% | -82.5% | -101.4% | -83.0% | -124.0% | -101.1% | -114.0% | -79.0% | -53.5% | -49.4% | -59.5% | -38.4% | -51.3% | -65.9% | -67.0% | -42.2% | -42.6% | -63.0% | -109.7% | -87.0% | -96.9% | -78.7% | -82.8% | -73.6% | -84.8% | -103.2% | -118.5% | -83.5% | -67.8% | -54.3% | -56.1% | -61.2% | -69.3% | -71.0% | -63.3% | -66.5% | -74.8% | -78.8% | -104.2% | -81.8% | |
| -141.4% | -87.7% | -70.1% | -89.2% | -69.1% | -108.5% | -83.9% | -97.5% | -63.9% | -35.0% | -36.7% | -47.2% | -29.0% | -42.0% | -36.3% | -55.7% | -34.2% | -28.9% | -51.1% | -97.3% | -77.8% | -88.9% | -72.2% | -76.5% | -70.3% | -81.8% | -98.3% | -112.8% | -76.1% | -61.6% | -48.1% | -50.2% | -55.1% | -63.2% | -66.9% | -55.4% | -59.5% | -59.8% | -58.1% | -81.5% | -64.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.